Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity. The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.